tiprankstipranks
Oncology Institute, Inc. (TOI)
:TOI
US Market

Oncology Institute, Inc. (TOI) Earnings Dates, Call Summary & Reports

Compare
76 Followers

Earnings Data

Report Date
May 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
Last Year’s EPS
-0.21
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 24, 2025
|
% Change Since: 14.00%
|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and strategic expansions into new markets, with improved financial flexibility from debt reduction and capital raises. However, the company continues to face profitability challenges, with a net loss and negative adjusted EBITDA reported for 2024. Efforts to improve cash flow and cost efficiency are promising, but overall profitability remains a challenge.
Company Guidance
During The Oncology Institute, Inc.'s fourth-quarter and full-year 2024 earnings call, the company provided several key metrics and guidance for 2025. The Institute reported a consolidated revenue of $100.3 million for Q4 2024, reflecting a 17% increase from Q4 2023, primarily driven by dispensary revenue. For 2025, they anticipate revenue growth of 17% to 22%, totaling $460 million to $480 million, with significant contributions from new capitation contracts, particularly in the Florida market. Gross profit for 2024 was $54 million, with expectations to rise to $73 million to $82 million in 2025, marking an improvement in margins. Despite a net loss of $64.6 million in 2024, the company aims to achieve positive EBITDA by Q4 of 2025, driven by strategic cost management and a focus on operational efficiency. They also expect free cash flow between negative $12 million to negative $21 million for 2025, with a breakeven target in Q4. Additionally, the company has made progress in reducing SG&A expenses by 12% in Q4 2024 compared to the same period in 2023 and has strengthened its balance sheet with a $20 million debt paydown and a $16.5 million private equity placement.
Revenue Growth
The Oncology Institute, Inc. reported a fiscal year 2024 revenue increase of 21.3% compared to 2023, driven by contributions from the California-based pharmacy and new capitation contracts.
Expansion into New Markets
The company successfully entered new markets outside of California, with significant contracts in Florida totaling over 200,000 lives, further expanding to 80,000 additional lives in early 2025.
Improved Financial Position
The Oncology Institute, Inc. reduced outstanding debt from $110 million to $86 million by early 2025 and raised $16.5 million in a private placement, improving financial flexibility.
Cash Flow Improvements
The company generated over $4 million of cash in Q4 2024, marking the second consecutive quarter of positive cash from operations.
Cost Efficiency
SG&A expenses decreased by 12% in Q4 2024 compared to Q4 2023, demonstrating operational efficiency and strategic execution.
---

Oncology Institute, Inc. (TOI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TOI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 20252025 (Q1)
- / -
Mar 24, 20252024 (Q4)
- / -0.14
-0.2133.33% (+0.07)
Nov 13, 20242024 (Q3)
- / -0.18
-0.195.26% (+0.01)
Aug 13, 20242024 (Q2)
-0.09 / -0.17
-0.1910.53% (+0.02)
May 14, 20242024 (Q1)
-0.12 / -0.22
-0.3333.33% (+0.11)
Mar 27, 20242023 (Q4)
-0.11 / -0.21
-0.16-31.25% (-0.05)
Nov 08, 20232023 (Q3)
-0.13 / -0.19
-0.17-11.76% (-0.02)
Aug 08, 20232023 (Q2)
-0.17 / -0.19
-0.09-111.11% (-0.10)
May 10, 20232023 (Q1)
- / -0.33
0.253-230.43% (-0.58)
Mar 09, 20232022 (Q4)
-0.20 / -0.16
-0.15-6.67% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TOI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 24, 2025$1.00$1.24+24.00%
Nov 13, 2024$0.26$0.24-7.69%
Aug 13, 2024$0.55$0.45-18.18%
May 14, 2024$0.90$0.68-24.44%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Oncology Institute, Inc. (TOI) report earnings?
Oncology Institute, Inc. (TOI) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
    What is Oncology Institute, Inc. (TOI) earnings time?
    Oncology Institute, Inc. (TOI) earnings time is at May 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TOI EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis